Special Learning, Inc., the leading global provider of Autism Spectrum Disorder and Applied Behavior Analysis (ABA) mobile applications and educational resources for those affected by autism, today announced its latest webcast, “Psychopharmacology of Autism Spectrum Disorders,” is scheduled for June 21, 2012.

Autism expert Luc Lecavalier, Ph.D., an Associate Professor of Psychology and Psychiatry at the Ohio State University, is the presenter for this highly educational webcast topic. The webcast is 120 minutes and includes 100 minutes of content and a 20-minute live question and answer section with Dr. Lecavalier. Attendees will be eligible for two BCBA, BCaBA and psychology continuing education credits.

“The partnership between Dr. Lecavalier and Special Learning continues to show our desire to provide those in the autism community with the most up-to-date information and relevant treatment options to battle the condition,” said Michele LaMarche, BCBA and co-founder of Special Learning. “Through our series of educational webcasts and by partnering with such experts as Dr. Lecavalier, we’re able to offer the most relevant and up-to-date information for those serving the ASD community and those affected by it.”

Dr. Lecavalier is a licensed psychologist with 15 years of clinical and research experience in the developmental disabilities field. He has co-authored more than 60 publications and in 2008 received the Early Career Awards from both the American Association of Intellectual and Developmental Disabilities and Division 33 of the American Psychological Association.

Lecavalier is a member of the Editorial Board of the Journal of Autism and Developmental Disorders and an Associate Editor of Autism: the International Journal of Research and Practice.

Topics covered in the webcast include:

• Basic pharmacological processes
• Use of psychotropic medicines
• Prevalence of use of psychotropic medicines in ASD
• Different classes of psychotropic medicines, such as stimulants, antidepressants, mood stabilizers, antispychotics, antiepileptics and anxiolytics
• Monitoring and measuring the effects of medicines
• Clinical conditions and target symptoms associated with psychotropic medicine use
• Review of scientific studies on psychotropic medicines in children and adolescents with ASD

The webcast provides information about effective service delivery systems for children and adolescents with a diagnosis of ASD and their families, across a diverse range of backgrounds. It is inclusive information for all young people with ASD, regardless of gender, race, culture, ethnicity and economic status.

“Autism is quickly becoming an epidemic throughout the United States and across the globe and to counter its prevalence, we need to continue developing solutions to curb its affects,” said LaMarche. “We also need to seek evidence-based research outcomes that provide long-term solutions to ensure our children achieve quality lives.”

According to the Centers for Disease Control and Prevention, autism affects one in 88 children in the United States alone and is quickly becoming one of the most prevalent disorders affecting children. With estimated growth rates of between 10 percent to 17 percent annually, autism is reaching epidemic proportions.

To register for the webinar, visit: http://www.special-learning.com/webinar/june/psychop¬harmacology. For more information about Special Learning, visit: http://www.special-learning.com.

About Special Learning
Special Learning is the leading global provider of autism and Applied Behavior Analysis (ABA) solutions. Special Learning designs mobile applications and educational resources based on clinical evidence-based research to ensure that every person diagnosed with Autism Spectrum Disorder (ASD) is capable of attaining an abundant and fulfilling life. Through its comprehensive web portal, Special Learning provides the global autism community with a range of ABA training and educational products, web-based and downloadable tools and professional services to empower parents, teachers and providers so that they can help individuals with autism move up the skills spectrum intuitively, successfully and affordably.